Association with serum levels of thyroid hormones provides an interesting link, with the potential clinical utility of FT4 concentrations in monitoring thyroxine replacement therapy in people with obesity or in identifying persons at higher risk of developing specific complications of obesity. This evidence concerns the gene TG and Obesity.